Videos

Improving Outcomes in Corneal Endothelial Disease With Cell Therapy

Greg Kunst, chief executive officer, Aurion Biotech, discussed the potential of cell therapy in treating people with corneal endothelial disease around the world.

Cilta-Cel's Efficacy in Heavily Pretreated Patients With Multiple Myeloma: Thomas G. Martin, MD

The clinical professor of medicine, Helen Diller Family Comprehensive Cancer Center, UCSF, discussed data from the CARTITUDE-1 study presented at ASH 2021.

Improving Specificity of T-Cell Therapies in Solid Tumors: Julian Molina, MD, PhD : Julian Molina, MD, PhD

The hematologist/oncologist from Mayo Clinic discussed advantages of Tmod technology in solid tumors.